(Q24245394)

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

N-3 fatty acids for the treatment of inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

Effect of fish oil enriched enteral diet on inflammatory bowel disease tissues in organ culture: differential effects on ulcerative colitis and Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

Omega-3 fatty acids in inflammation and autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

Effects of dietary fish oil supplementation on polymorphonuclear leukocyte inflammatory potential

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn's disease patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

n-3 fatty acids only delay early relapse of ulcerative colitis in remission

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

Enteral absorption in man of eicosapentaenoic acid in different chemical forms

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

Is fish oil (n-3 fatty acids) effective for the maintenance of remission in Crohn's disease?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

CLA and n-3 PUFA differentially modulate clinical activity and colonic PPAR-responsive gene expression in a pig model of experimental IBD.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

Human absorption of fish oil fatty acids as triacylglycerols, free acids, or ethyl esters

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

Prevalence of essential fatty acid deficiency in patients with chronic gastrointestinal disorders

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

A simple index of Crohn's-disease activity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

Assessing the quality of randomized trials: reliability of the Jadad scale

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

Serum n3 polyunsaturated fatty acids are depleted in Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

Bone turnover and nutritional status in Crohn's disease: relationship to circulating mononuclear cell function and response to fish oil and antioxidants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

Reduced joint pain after short-term duodenal administration of seal oil in patients with inflammatory bowel disease: comparison with soy oil.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

Essential fatty acid depletion in children with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

Insulin-like growth factors (IGFs) and IGF binding proteins in active Crohn's disease treated with omega-3 or omega-6 fatty acids and corticosteroids

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

Supressive effect of maslinic acid from pomace olive oil on oxidative stress and cytokine production in stimulated murine macrophages

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

Fish oil and antioxidants alter the composition and function of circulating mononuclear cells in Crohn disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

Distribution, interconversion, and dose response of n-3 fatty acids in humans

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

n-3 fatty acids and gene expression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

Summary of a workshop on n-3 fatty acids: current status of recommendations and future directions

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

Dietary polyunsaturated fatty acids improve histological and biochemical alterations in rats with experimental ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

Hepatosplenic T-cell lymphoma in an adolescent patient after immunomodulator and biologic therapy for Crohn disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

Dietary fat attenuates the benefits of an elemental diet in active Crohn's disease: a randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

Nutritional supplementation with N-3 fatty acids and antioxidants in patients with Crohn's disease in remission: effects on antioxidant status and fatty acid profile

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

Lipid treatment of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

Omega-3 fatty acids inhibit an increase of proinflammatory cytokines in patients with active Crohn's disease compared with omega-6 fatty acids

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

The health benefits of omega-3 polyunsaturated fatty acids: a review of the evidence

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease--a randomized, placebo-controlled, double-blind cross-over trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

Can fish oil maintain Crohn's disease in remission?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

Systematic reviews in health care: Assessing the quality of controlled clinical trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of granulomatous colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

Incorporation of fatty acids from fish oil and olive oil into colonic mucosal lipids and effects upon eicosanoid synthesis in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

Short-term efficacy of enteral nutrition in the treatment of active Crohn's disease: a randomized, controlled trial comparing nutrient formulas

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Study Group Members (German Crohn's Disease Study Group).

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006320.PUB2

7 January 2021

10.1002/14651858.CD006320.PUB2

Identifiers

DOI

0 references

Fatcat ID

release_u7fzbzotyrcd3plyzhksi5ty2q

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/u7fzbzotyrcd3plyzhksi5ty2q

24 November 2022